Catalyst Wire Dossier Catalyst Wire Dossier

Timolol maleate 0.5% / Dorzolamide 2% fixed combination

timolol maleate 0.5% / dorzolamide 2% fixed combination
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Timolol maleate 0.5% / Dorzolamide 2% fixed combination, covering 2015-08-18 to 2015-08-18. Get the full timeline:

Most recent: Clinical Trial Update: Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure [Phase 4]

See pricing